Working… Menu

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19: (E-SPERANZA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04695704
Recruitment Status : Not yet recruiting
First Posted : January 5, 2021
Last Update Posted : March 8, 2021
Institut Català de la Salut
Information provided by (Responsible Party):
Jordi Gol i Gurina Foundation

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : March 31, 2022
Estimated Study Completion Date : December 31, 2022